Medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale)

In 2024, medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale) trade exhibited significant decline, with global flows reaching $18,438,985 and a three-year compound annual growth rate of -10.5% (five-year: -14.7%). The all-time peak of $54,388,680 was recorded in 2018; the current level is 66% below that high-water mark.

Over the 30-year observation window (1995–2024), 55% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is decelerating (-3.7% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.462). The three largest exporters — Malaysia ($12.5M), Lithuania ($12.3M), and United Kingdom ($5.2M) — collectively dominate supply flows. The leading exporter has grown at -69.7% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.457). The three largest import markets are Sweden ($12.3M), Ukraine ($3.0M), and United States ($1.8M). The largest importing market sources from 4 different supplying countries.

The dominant trade corridor is Lithuania → Sweden at $12.3M, representing 99.8% of the importer's total demand.

The volatility score for medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, (not packaged for retail sale) is 14 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.